MRI Study of Subjects with ASD, Their Relatives and TD

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-13

Study Completion Date

2039-09-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project is structured around a central study called "Study of genetic factors involved in autism and related conditions ("Genes and Autism" study, sponsor: INSERM). This study explores clinical and genetic aspects of ASD (autism spectrum disorders) and is complemented with several ancillary studies (such as this one) which will use the data of the main study and will allow an extensive review of phenotypes associated with ASD.

In this ancillary study, we will go on the acquisition of anatomical, diffusion and functional MRI in subjects with ASD, relatives and controls. Our group has already performed several neuroanatomical studies of ASD. IWe recruited since 2010 more than 600 subjects (proponents, relatives and controls) to better understand the implication of brain abnormalities in ASD.

This study involves specialized teams in neuroiamging based at INSERM, NeuroSpin (CEA), Robert Debré Hospital (APHP) and Pasteur Institute

Our main objective is to identify structural, connectivity and functional peculiarities in subjects with ASD

Secondary objectives include:

* the identification of familial heritability patterns of ASD
* correlate data obtained in brain imaging with genetic data
* assess specificity and statistical reproducibility of the obtained results

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MRI Study of Cerebral Blood Flow in Development Disorders in Children

NCT02165410

Autism

UNKNOWN NA

MRI Brain (Volumetry, fMRI & MRS) in Autism

NCT05758220

Autism Spectrum Disorder

UNKNOWN

Magnetic Resonance Imaging of Brain Development in Autism

NCT00449566

Autism

UNKNOWN

Brain Imaging in Children With AD/HD

NCT00008892

Attention Deficit Disorder With Hyperactivity Healthy

COMPLETED

Advanced MRI in Blast-related TBI

NCT00785304

Traumatic Brain Injury

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects with Autism Spectrum Disorders

Neuroimaging (MRI)

Intervention Type OTHER

Multimodal magnetic resonance imaging

Relatives of subjects with Autism Spectrum Disorders

Neuroimaging (MRI)

Intervention Type OTHER

Multimodal magnetic resonance imaging

Typically developing subjects

Neuroimaging (MRI)

Intervention Type OTHER

Multimodal magnetic resonance imaging

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuroimaging (MRI)

Multimodal magnetic resonance imaging

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* for patients:

* being included in the main study "C16-89 - Study of genetic factors involved in ASD and related disorders"
* having an ASD fulfilling DSM-5 diagnostic criteria (APA, 2012). Diagnosis will be done by a clinical expert, with the support of structured instruments (ADI-R, ADOS-2)
* having at least 24 Months
* being affiliated with the French health insurance
* having signed the informed consent (by proposant or by legal tutors if the subject is \<18 or under legal custody)
* for relatives

* being included in the main study "C16-89 - Study of genetic factors involved in ASD and related disorders"
* having at least 24 Months
* being affiliated with the French health insurance
* having signed the informed consent (by proposant or by legal tutors if the subject is \<18 or under legal custody)
* for controls

* being included in the main study "C16-89 - Study of genetic factors involved in ASD and related disorders"
* having at least 24 Months
* being affiliated with the French health insurance
* having signed the informed consent (by proposant or by legal tutors if the subject is \<18 or under legal custody)

* for all subjects

* severe mental retardation (IQ\<35 or developmental age\<18 months)
* medical condition (either psychiatric or physical) not compatible with an inclusion
* MRI counter indication
* Current pregnancy or breastfeeding, assessed by questionnaire
* Not willing to be informed of a brain abnormality diagnosed with MRI
* for the relatives

\*discovery of non filiation during the genetic analyses
* for controls

* Neurological history (except mental retardation)
* Personal history of (checked with DIGS for Adults, Diagnostic Interview for Genetic Studies, Numberger et coll., 1994, or Kiddie SADS, Kiddie Schedule for Disorders and Schizophrenia for School Age Children, Orvaschel et coll., 1982): schizophrenia, addiction, bipolar disorder, recurrent depression (\> 2 episodes lifetime), severe, not stabilized anxiety disorder, history of episodes of epilepsy, significant inflammatory disease of immunosuppressive medication

Exclusion Criteria

* for patients: ASD diagnosis not confirmed by assessments after the inclusion
* for all subjects: discovery of a counter indication to MRI during the exam (e.g. claustrophobia)

Minimum Eligible Age

24 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes